Background-Cardiac overload, a major cause of heart failure, induces the expression of the heat shock protein H11 kinase/Hsp22 (Hsp22). Methods and Results-To determine the specific function of Hsp22 in that context, a knockout mouse model of Hsp22 deletion was generated. Although comparable to wild-type mice in basal conditions, knockout mice exposed to pressure overload developed less hypertrophy and showed ventricular dilation, impaired contractile function, increased myocyte length and accumulation of interstitial collagen, faster transition into heart failure, and increased mortality. Microarrays revealed that hearts from knockout mice failed to transactivate genes regulated by the transcription factor STAT3. Accordingly, nuclear STAT3 tyrosine phosphorylation was decreased in knockout mice. Silencing and overexpression experiments in isolated neonatal rat cardiomyocytes showed that Hsp22 activates STAT3 via production of interleukin-6 by the transcription factor nuclear factor-B. In addition to its transcriptional function, STAT3 translocates to the mitochondria where it increases oxidative phosphorylation. Both mitochondrial STAT3 translocation and respiration were also significantly decreased in knockout mice. Conclusions-This study found that Hsp22 represents a previously undescribed activator of both nuclear and mitochondrial functions of STAT3, and its deletion in the context of pressure overload in vivo accelerates the transition into heart failure and increases mortality. (Circulation. 2011;124:406-415.)
E xpression of the heat shock protein H11 kinase/Hsp22 (Hsp22) is restricted to a limited number of tissues, including the heart and skeletal muscle, in both rodents and humans, 1 and it rapidly increases in response to excessive contractile workload (overload). 2 We previously showed in a transgenic (TG) mouse model that cardiac-specific overexpression of Hsp22 induces a pattern of stable cardiac hypertrophy with normal function. 2, 3 However, because of some redundancy in the function of small-molecularweight Hsps, 4 the precise function of Hsp22 in the response to overload remains unclear, and it is unknown whether Hsp22 expression is necessary for the physiological and molecular response of the heart exposed to increased stress by overload.
Clinical Perspective on p 415
In the present study, we tested the hypothesis that Hsp22 expression is required for the activation of stress-responsive signaling pathways. We addressed that hypothesis using 2 complementary approaches, in vivo and in vitro. First, we generated a knockout (KO) mouse model to investigate the consequences of Hsp22 deletion in a context of pressureinduced overload and found that a lack of Hsp22 accelerates ventricular dysfunction and remodeling, as well as the transition into heart failure. This phenotype corresponds to a lack of activation of genes transactivated by STAT3, a stressinducible transcription factor promoting cardiac cell survival that is essential for adaptive growth on overload. 5 Intrigu-ingly, it was shown recently that mitochondrial translocation of STAT3 also promotes oxidative phosphorylation 6 and that function was impaired in our KO model. Second, we manipulated Hsp22 expression in isolated cardiac myocytes to determine the signaling mechanisms involved.
These results illustrate a previously undescribed mechanism of cardiac response to overload, and in particular a novel mode of regulation of both nuclear and mitochondrial STAT pathways. Activation of this novel signaling may be of clinical relevance for patients exposed to long-term excessive workload and at risk of subsequent cardiac damage.
Methods
Methods are detailed further in the online-only Data Supplement. All animal investigations conform with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (publication No. 85-23, revised 1996).
Generation of the Construct for H11 Kinase/Heat Shock Protein 22 Deletion
We generated a 12-kb construct in which the first exon of the Hsp22 gene is targeted for deletion on recombination. The left and right arms of the construct are 5 and 7 kb long, respectively. The left arm is integrated by XhoI sites and the right arm by XbaI sites. The targeted exon is flanked by loxP sites. Probes were generated outside the construct on both sides for detection of positive clones by Southern blot using SpeI and EcoRI digests, respectively.
Surgical Procedures
Surgery was performed on 3-to 4-month-old male wild-type (WT) and KO mice. To generate pressure overload, mice were submitted to transverse aortic constriction (TAC) with a 28-gauge needle as before. 7 All mice surviving the surgery were included in the study. Age-matched sham-operated control animals were included.
Tissue Extraction and Western Blot
Heart tissues were homogenized at 4°C in a lysis buffer. 2, 3, 7, 8 Subcellular fractions were prepared by differential centrifugation. 3 Protein extracts were denatured, resolved on SDS-PAGE gels, and transferred to membranes. After incubation with the secondary antibody, detection was performed by chemiluminescence.
Histopathology
Samples were fixed in 10% formalin and cut into 7-m-thick sections. Tissue sections were stained with picric acid Sirius red to identify collagen. 9 Myocyte cross-sectional area was determined on digitized images of TRITC-labeled wheat germ agglutinin-stained sections. 3, 7 Terminal deoxynucleotidyl transferase dUTP nick-end labeling was performed as described. 10 Nuclear counterstaining was performed with DAPI.
Microarray Data Analysis
Messenger RNA was purified, reverse transcribed, 11, 12 and subsequently transcribed into biotin-labeled synthetic antisense RNA 12 before hybridization (GeneChip 430.2.0, Affymetrix, Santa Clara, CA). Bioinformatics analysis of the microarray data was performed with the Welch t test using a value of PϽ0.05 and a fold change Ͼ1.2 to select significant genes. 12 For the gene density map, all genes were evenly divided into 20 groups based on fold change in each comparison and then distributed in a 20ϫ20 table. The number of genes in each cell was normalized to an expected number derived from randomized data. Transcription factor binding sites were obtained from the Molecular Signature Database. 13 Gene ontology and transcription factor binding sites analyses were carried out with hypergeometric tests. Genes regulated by STAT3 were derived from a previous study 14 and from the Ingenuity Pathway analysis database. The STAT3 target genes were compared with other genes on the microarray using the cumulative distribution function based on log2 ratio (fold change). Microarray data were deposited in the Gene Expression Omnibus database (GSE24489).
Quantitative Reverse Transcription Polymerase Chain Reaction
After reverse transcription of the mRNA of interest from 50 ng total RNA, the cDNA was used for quantitative polymerase chain reaction (40 cycles of a 10-second step at 95°C and a 1 minute-step at 60°C) using the SybrGreen method on a 7300 ABI-Prizm Sequence Detector (Applied Biosystems, Foster City, CA). 15 Values are reported per cyclophilin transcript to correct for sample-to-sample RNA loading variations.
Mitochondrial Oxygen Consumption
After extraction, mitochondria (0.4 mg/mL) were incubated in a respiration buffer containing 100 mmol/L KCl, 50 mmol/L sucrose, 10 mmol/L HEPES, 5 mmol/L KH 2 PO 4 , pH 7.4, at 30°C. The following parameters of mitochondrial respiration were evaluated with a Clark-type electrode: substrate-dependent respiration rate (states 2 and 4) in the absence of exogenous ADP, ADP-stimulated respiration rate (state 3), and respiration uncoupling in presence of 0.2 mol/L carbonyl cyanide 4-trifluoromethoxyphenylhydrazone (FCCP).
Culture of Cardiac Myocytes
Neonatal rat cardiac myocytes were prepared as before. 2, 16, 17 The adenovirus harboring the Hsp22 sequence was described previously. 2, 17 An adenovirus harboring LacZ was used as a negative control. Knockdown of Hsp22 was performed as described previously, 18 with luciferase silencing used as a negative control. 18 Interleukin-6 (IL-6) release was measured with the Quantikine rat IL-6 ELISA kit (R&D Biosystems, Minneapolis, MN). For DNA binding activities, myocytes were transfected with 20 -multiplicity of infection Cignal lentivirus particles designed for STAT3 and nuclear factor-B (NF-B) reporter assays (SABiosciences, Frederick, MD), and firefly luciferase activity was measured with the Luciferase Reporter Gene Assay (Roche, Indianapolis, IN).
Adult cardiac myocytes were prepared by retrograde perfusion of the hearts in the presence of collagenase (type II, Worthington) and 0.1 mg/mL protease (type XIV, Sigma). 19 Cell length, defined as the longest length parallel to the longitudinal axis of the myocytes, was measured by an imaging system.
Statistical Analysis
Results are presented as the meanϮSEM for the number per group indicated in each figure legend. The Student t test was used for 2-group comparison. For comparisons of Ͼ2 groups, statistical analysis was performed by 2-by-2 factorial designs (2 groups exposed to 2 conditions) and 1-way (multiple groups exposed to 1 condition) and 2-way (multiple groups exposed to 2 conditions) ANOVA with Bonferroni post hoc correction. Survival curves were compared with the Kaplan-Meier estimators, and their significant difference was determined with the log rank test.
Results

Hsp22 Deletion Does Not Affect Basal Cardiac Structure and function
A construct targeting exon 1 of the Hsp22 gene ( Figure 1A ) was electroporated in 129 embryonic stem cells and subsequently injected in blastocysts of C57 mice. Mice with germline transmission of the construct were crossed with a CMV-Cre (C57) mouse to trigger the recombination of the construct, followed by crossing for 5 generations in a C57 background to obtain a homozygous mouse in which both Hsp22 alleles are deleted. The KO mice were born at mendelian distribution. The heterozygous mice express an amount of Hsp22 protein equivalent to that found in WT mice ( Figure 1A) .
The physiological and morphological characteristics of the KO mouse in basal conditions are shown in the Table I in the online-only Data Supplement. The KO mouse was comparable to the WT mouse in terms of body weight, left ventricular weight, and lung weight. There was no difference between KO and WT mice in terms of cardiac dimensions, measured by echocardiography, and of cardiac contractility, as assessed by ejected volume and developed pressures. At histology, there was no difference between KO and WT in terms of cell size, apoptosis, and collagen accumulation.
Hsp22 Deletion Precipitates Heart Failure on Pressure Overload
Both WT and KO mice were submitted to TAC for 2 weeks to determine the consequences of Hsp22 deletion on cardiac function and histology under cardiac stress. On TAC, Hsp22 was still detected specifically in myocytes as opposed to nonmyocytic cells ( Figure I in the online-only Data Supplement). The pressure gradient induced by TAC was comparable between groups (80Ϯ10 versus 67Ϯ8 mm Hg in WT and KO, respectively). Functional measurements by echocardiography and hemodynamics showed that WT mice responded to TAC by an increase in wall thickness, left ventricular enddiastolic pressure, and ratio of lung weight to tibial length, as well as a decrease in ejection fraction ( Figure 1B ). All these parameters were also significantly affected in KO mice submitted to TAC. However, compared with WT mice, KO mice showed significantly less wall thickening and increased left ventricular diameter, resulting in higher wall stress, whereas the decrease in ejection fraction was significantly more important ( Figure 1B ). The deterioration of contractile function in hearts from banded KO mice was accompanied by a higher increase in left ventricular end-diastolic pressure and ratio of lung weight to tibial length compared with WT mice ( Figure 1B ). In addition, the mortality rate after TAC was doubled in KO compared with WT mice ( Figure 1C ). Considering the loss in cardiac function observed in KO mice after TAC, we assume that mice died of contractile dysfunction.
At histology, the myocyte cross-sectional area after TAC increased significantly more in WT than in KO mice ( Figure  2A and 2B). Reciprocally, cell length increased significantly more in KO than in WT mice (Figure 2A and 2B), reflecting a pattern of eccentric hypertrophy in the KO, in agreement with the functional measurements shown in Figure 1 . Measurement of cell volume confirmed that the KO mouse develops hypertrophy on TAC, although to a significantly lesser extent than the WT mouse ( Figure 2B ). The surface of myocardium covered by collagen after TAC was significantly higher in KO mice (Figure 2A and 2B), and this was accompanied by a higher expression of the matrix metalloproteinase-2 in KO compared with WT mice ( Figure  II in the online-only Data Supplement). However, the TACinduced increase in apoptosis was comparable between both groups at that time point ( Figure 2B ). Therefore, Hsp22 deletion does not affect cardiac structure and function in basal conditions. However, it precipitates heart failure, increases mortality, and accelerates ventricular remodeling in the context of pressure overload.
Hsp22 Deletion Impairs the Activation of Stress-Activated Survival Pathways
Because KO mice show extensive phenotypic differences compared with WT mice at 2 weeks after TAC, we sought to determine which early events could be the cause, rather than the consequence, of altered function. For that purpose, mice were submitted to TAC for 3 days, a time point at which cardiac function was comparable between WT and KO mice Figure 1 . Characteristics of the knockout (KO) mouse submitted to pressure overload. A, Generation of the heat shock protein H11 kinase/Hsp22 (Hsp22) KO mouse. Construct design (gray box is exon 1) and Hsp22 expression in wildtype (WT), heterozygous, and KO mice in various tissues. B, Functional characteristics of WT and KO mice (nϭ6 per group) in basal conditions (sham) and after 2 weeks of transverse aortic constriction (TAC). The graphs show the left ventricular (LV) septal wall thickness, end-diastolic diameter (EDD), wall stress, ejection fraction, end-diastolic pressure (EDP), and lung weight/tibial length (LW/ TL). C, Survival curve of WT and KO mice after TAC and followed up for 2 weeks (n Ն20 per group; there was no additional mortality in either group after day 7). *PϽ0.05 vs corresponding sham; #PϽ0.05 vs corresponding WT (2-by-2 analysis).
(not shown). We showed before that Hsp22 activates the phosphatidylinositol-3 kinase/Akt growth pathway via the bone morphogenetic protein receptor. 18 Phosphorylation of Akt (S473) was comparable between WT and KO in shamoperated animals ( Figure 3 ). After TAC, however, KO mice showed significantly less phosphorylation of Akt (60% of WT). Activation of the bone morphogenetic protein receptor, as determined by Smad 1/5/8 phosphorylation, 18 was significantly impaired in KO after TAC ( Figure 3 ). Another pathway mediating cardiac cell growth and survival is represented by extracellular receptor kinase (ERK) 1 and 2. The phosphorylation of both ERK1 and ERK2 was comparable between WT and KO mice in sham conditions ( Figure 3 ). After TAC, phosphorylation of ERK1/2 increased in WT but dramatically decreased in KO (ERK1, 12% of WT; ERK2, 10% of WT; both PϽ0.05). Other survival mechanisms activated by Hsp22 include the inducible isoform of nitric oxide synthase (iNOS) 8 and Hsp70. 8 In sham-operated KO mice, the abundance of iNOS was only 35% of that found in corresponding WT mice ( Figure 3 ). After banding, iNOS expression was not significantly affected in WT, but it was almost abolished in KO mice ( Figure 3 ). Expression of Hsp70 after TAC was doubled in KO compared with WT mice (Figure 3 ), most likely as a compensatory mechanism. 
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Hsp22 Deletion Impairs Stress-Activated Gene Expression
To explore the mechanism causing the deteriorating phenotype of the KO mouse on TAC, both WT and KO mice were compared by microarray analysis in basal conditions and 3 days and 2 weeks after TAC. Among Ͼ14 000 genes analyzed, only 291 and 153 genes were upregulated or downregulated, respectively, in sham KO compared with WT mice ( Figure 4A ). After 3 days of TAC, the number of genes upregulated in the KO compared with WT mice was similar to that found in sham-operated animals (248), whereas the number of genes downregulated in KO mice increased by Ͼ3-fold ( Figure 4A ). Two weeks after TAC, the number of differently regulated genes between WT and KO was again roughly similar to that found in sham ( Figure 4A ). Comparison of gene profiles by Venn diagram between sham and 3 days of TAC ( Figure 4B) shows that the identity of the regulated genes differs completely between both conditions. This difference is confirmed by the lack of similarity for significant ontology terms associated with the regulated genes ( Table II in the online-only Data Supplement). The large number of genes with lower expression in KO compared to WT mice 3 days after TAC, together with the comparison of the Venn diagrams, suggests a lack of activation of stress-induced genes at the acute phase of TAC in the KO mouse. Further analysis was performed by gene density map and by transcription factor binding sites analysis. The gene density map presented in Figure 4C shows on the y axis the genomic differences between 3 days of TAC and sham in WT mice, which represents the normal gene response to overload, and on the x axis the differences between KO and WT mice 3 days after TAC. A cluster of genes was found to be upregulated in the normal response to overload but downregulated in KO compared with WT mice ( Figure 4C ). When grouped by ontology terms, these genes correspond mainly to the inflammatory response. Transcription factor binding sites analysis was used to determine whether this downregulated inflammatory response in KO corresponds to specific transcription factors. Among the few transcription factor binding sites found to be significantly associated with genes with lower expression in KO mice ( Table III in the online-only Data Supplement), we found the cytokine-responsive interferon-stimulated response element, which activates genes related to the inflammatory response.
A main activator of interferon-stimulated response element/inflammatory response in the heart is the transcription factor STAT, which is essential for the cardiac stress response to overload. To examine more specifically whether STAT plays a role in gene regulation in Hsp22 KO, we compared genes that were previously annotated as STAT3-regulated genes 14 with the other genes on the microarray with respect to expression differences in WT versus KO 3 days after TAC ( Figure 4D ). We found that, compared with other genes, a higher fraction of STAT3-regulated genes have significantly lower expression in KO than in WT ( Figure 4D ), suggesting that these genes have an attenuated response to pressure overload in KO. These results were further validated by differences of regulated genes between KO and WT in sham and after 3 days of TAC. C, Gene ontology categories, corresponding to genes with lower expression in KO vs WT 3 days after TAC, are indicated. The gene density map reflects distribution of genes, with color corresponding to the scale shown. For example, "ϩ40%" and "Ϫ40%," shown as red and blue, indicate 40% enrichment and 40% depletion, respectively. D, Expression changes of STAT3-regulated genes in heat shock protein H11 kinase/Hsp22 (Hsp22) KO 3 days after TAC. STAT3annotated genes were compared with other genes on the microarray using the cumulative distribution function based on log2 ratio (fold change). The black dotted curve is for STAT3-regulated genes; the gray curve, for other genes. For each curve, the fraction of genes at which log2(ratio)ϭ0 is indicated. The P value indicating the difference between both curves is calculated from the Kolmogorov-Smirnov test.
quantitative polymerase chain reaction, showing that representative STAT3-annotated genes were downregulated in KO mice compared with WT not only after TAC but also in sham conditions ( Figure 5 ).
Hsp22 Modulates Both Nuclear and Mitochondrial Function of STAT3
On the basis of this information, the regulatory function of Hsp22 on the STAT pathway was further explored in vivo. In the heart, the main subtypes of STAT transcription factors are STAT1 and STAT3, with STAT1 being mainly proapoptotic and STAT3 promoting survival. 20 STAT transcriptional activity is stimulated by tyrosine phosphorylation. 5 Besides its role as a transcription factor, STAT3 was recently shown to translocate to the mitochondria, where it activates the electron transport chain on serine phosphorylation. 6 Therefore, we tested in subcellular fractions ( Figure 6A ) whether Hsp22 expression affects the nuclear and/or mitochondrial regulation of STAT in vivo. For these experiments, we compared the consequences of downregulation versus upregulation of Hsp22 expression by using not only our Hsp22 KO mouse but also an Hsp22 TG mouse with cardiac-specific overexpression of Hsp22, which was described before. 2 Immunoblotting in nuclear fractions from hearts of KO compared with WT mice showed no significant difference in the abundance of total STAT3; however, tyrosine-phosphorylated (Y705; P) STAT3 was decreased by Ϸ50% in the KO mice ( Figure 6B ). Reciprocally, both STAT3 and P-STAT3 were significantly more abundant in nuclear fractions from the TG mouse compared with its corresponding WT ( Figure 6B ). Phosphorylation of nuclear STAT1 was also affected in both mouse models; however, its phosphorylation pattern showed a mirror image compared with STAT3; ie, it was increased in the KO and decreased in the TG mouse ( Figure 6B) .
Similar experiments were conducted in mitochondrial fractions. Expression of STAT3 was decreased by 40% in KO and increased by 2-to 3-fold in TG mice compared with WT ( Figure 6C ). Phosphorylation of mitochondrial STAT3 on S727 was also increased in TG compared with WT mice ( Figure 6C) .
The intramitochondrial localization of STAT3 and Hsp22 was confirmed on treatment of mitochondrial fractions with digitonin, which dissociates the outer mitochondrial membrane but leaves intact the mitoplast, including the inner mitochondrial membrane and the mitochondrial matrix. Treatment of mitochondria with 2% digitonin followed by centrifugation led to the release of porin, a marker of outer mitochondrial membrane, in the supernatant, whereas complex III, a marker of the mitoplast, was left in the pellet, together with most of both STAT3 and Hsp22 ( Figure 6D ). The small amount of STAT3 and Hsp22 released in the supernatant ( Figure 6D ) could be due to the presence of these proteins in the intermembrane space or to slight mitochondrial damage. Immunoprecipitation of STAT3 from these fractions showed a coprecipitation of Hsp22, suggesting that both proteins interact in the mitochondria ( Figure 6E ).
Next, we determined the impact of these findings on mitochondrial respiration in both TG and KO sham-operated mice ( Figure 6F) . Absolute values of mitochondrial respiration are presented in Table IV in the online-only Data Supplement. Both respiration state 3 (ADP stimulated) and states 2 and 4 (substrate dependent) were reciprocally regulated in TG versus KO mice ( Figure 6F ). In addition, the ADP/oxygen ratio and the respiratory control ratio of mitochondria isolated from KO were significantly decreased compared with WT, reflecting impaired respiratory coupling, but unaffected in TG ( Figure 6F ). Maximal stimulation of mitochondrial respiration by the uncoupling agent FCCP resulted in a 50% lower respiration rate in KO compared with WT mice, whereas it was increased in TG mice (Figure 6f ). Taken together, these results demonstrate a true limitation of the activity and coupling of the electron transport chain in KO mice but an increased activity in TG mice. Therefore, Hsp22 expression regulates the translocation, phosphorylation pattern, and physiological function of STAT3 in both nuclei and mitochondria.
Hsp22 Promotes the Activation of STAT3 by Nuclear Factor-B
We investigated more mechanistically in isolated neonatal rat cardiac myocytes how Hsp22 expression modulates STAT3 function using both adeno-mediated overexpression and silencing. Overexpression of Hsp22 in myocytes was sufficient to increase Y705 P-STAT3 phosphorylation in a dosedependent manner and overall STAT DNA binding activity and to reduce STAT1 phosphorylation ( Figure 7A ), in agreement with our observations in vivo. Immunofluorescence of cardiac myocytes infected with the Hsp22 adenovirus also showed a nuclear accumulation of Y705 P-STAT3 (Figure 7B). This observation does not result from an artifact caused by Hsp22 overexpression because it was also found on incubation of cardiac myocytes with insulin-like growth factor-1 ( Figure III Activation of STAT is promoted on binding of the gp130 receptor by specific ligands, including IL-6, leukemia-inhibitory factor, and cardiotrophin-1. 5 Expression of gp130, leukemia-inhibitory factor, and cardiotrophin-1 was not affected by Hsp22, but IL-6 abundance was significantly increased ( Figure 7C ). Interleukin-6 is a cytokine, and its release in the culture medium, as measured by ELISA, dose dependently increased in response to Hsp22 ( Figure 7C) . A known activator of IL-6 production in the heart is the transcription factor NF-B. 21 Overexpression of Hsp22 significantly increased NF-B DNA binding activity ( Figure  7C ). Addition of the NF-B inhibitor SN50 to cardiac myocytes blocked the Hsp22-mediated increase in STAT3 DNA binding ( Figure 7A ) and nuclear translocation ( Figure  7B ) and in IL-6 abundance ( Figure 7C ).
Using RNA silencing, we tested whether Hsp22 is required for NF-B-mediated activation of STAT3. Knockdown of Hsp22 was performed with a short-hairpin siRNA, and a nonrelevant short hairpin against luciferase was used for control experiments, as before. 18 In both groups, we measured STAT3 phosphorylation in basal conditions, on stimulation of NF-B, or on activation of the gp130 receptor. In basal conditions, Hsp22 silencing already decreased STAT3 phosphorylation compared with control ( Figure 7D ). On treatment of myocytes with IL-1␤, a known activator of NF-B, a significant increase in STAT3 phosphorylation was observed in the control group, which was prevented by Hsp22 silencing (Figure 7D) . Similarly, addition of the gp130 ligands IL-6 Figure 6 . Regulation of STAT by heat shock protein H11 kinase/Hsp22 (Hsp22). A, Subcellular fractionation using markers for cytosol (cyt), microsomes (mic), mitochondria (mit), and nuclei (nuc). B, Expression of Hsp22, STAT3, Y705-phosphorylated (P) STAT3, STAT1, and Y701 P-STAT1 in nuclear fractions from Hsp22 TG or knockout (KO) mice and respective wild-type (WT) littermates. Lamin A/C is used as a loading control. Bar graphs for nϭ3 per group. *PϽ0.05 vs corresponding WT (2-by-2 analysis). C, Expression of Hsp22, STAT3, and S727 P-STAT3 in mitochondrial fractions from Hsp22 transgenic (TG) or KO mice and respective WT littermates. The NADH dehydrogenase 1 alpha subunit 9 (NDUFA9) is used as a loading control. Bar graphs represent the meanϮSEM for nϭ3 per group. *PϽ0.05 vs corresponding WT (2-by-2 analysis). D, Treatment of mitochondrial fractions with 2% digitonin followed by centrifugation. Porin, used as a marker of outer mitochondrial membrane, is released into the supernatant on addition of digitonin, whereas complex III (Co. III), a marker of the mitoplast, remains in the undigested pellet, together with both STAT3 and Hsp22. E, Immunoprecipitation of STAT3 in mitochondrial fractions followed by western blotting for both Hsp22 and STAT3 in a heart sample from both WT and TG mice. The upper band for Hsp22 in the TG sample corresponds to the hemagglutinin-tagged transgenic product. Repeated immunoprecipitation (Re-IP) on a TG protein sample refers to a second incubation of the protein sample with the same antibody. Re-IP should not provide any band on immunoblotting if the protein of interest has been successfully depleted by the first immunoprecipitation. F, Measurement of mitochondrial respiration rate (states 2 through 4), state 3/4 respiration coefficient ratio (RCR), ADP/oxygen ratio, and maximal respiration under uncoupling by carbonyl cyanide 4-trifluoromethoxyphenylhydrazone (FCCP) in Hsp22 TG or KO mice and respective WT littermates (nϭ5 per group). *PϽ0.05 vs corresponding WT (1-way ANOVA). and leukemia-inhibitory factor markedly increased STAT3 phosphorylation in control conditions but not when Hsp22 was silenced ( Figure 7D ). This latter result implies that Hsp22-STAT3 interaction is necessary for the proper association of STAT3 with its receptor and hence its phosphorylation.
These results were validated in vivo. Plasma concentration of IL-6, as measured by ELISA, was significantly increased in TG compared with WT mice and decreased in KO compared with WT mice ( Figure 7E ). After TAC, IL-6 concentration increased markedly in WT mice but to a much lesser degree in KO mice ( Figure 7E) . Similarly, after TAC, Y705 STAT3 phosphorylation was reduced by Ϸ50% in KO compared with WT mice ( Figure 7E ).
Discussion
We demonstrate that Hsp22 deletion in the context of pressure overload in vivo promotes a pattern of ventricular eccentric hypertrophy and dilation; accelerates cardiac re-modeling and the transition into heart failure; increases mortality; interferes with the activation of cell survival pathways, including Akt, ERK, and iNOS; and prevents the activation STAT3-dependent stress-responsive genes. We show that Hsp22 deletion not only downregulates the activity of STAT3 as a transcription factor but also impairs mitochondrial STAT3 abundance and oxidative phosphorylation. We further demonstrate in vitro that Hsp22 is both sufficient and necessary for proper activation of STAT3 by another stressactivated transcription factor, NF-B ( Figure 7F ).
Hsp22 clearly represents a stress-responsive mechanism because the phenotype of the KO mouse is comparable to that of the WT mice under basal conditions. We found that Hsp22 expression increases rapidly during ventricular hypertrophy caused by overload. 2 Reproducing such an increase in an Hsp22 TG mouse creates a pattern of cardiac hypertrophy with normal function. 2, 3 We therefore hypothesized that Hsp22 deletion would impair the development of hypertrophy during overload. The results presented here show that, al- 
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though cardiac hypertrophy is not prevented, it is significantly decreased. The cardiac phenotype of the KO mouse quickly evolves into a pattern of eccentric hypertrophy, which significantly increased cardiac wall stress, yet it did not result in greater ventricular mass. The primary objective of the present study was to characterize the phenotype of the Hsp22 KO mouse under pressure overload. On the basis of the microarray data, we focused on STAT3 for the following reasons. First, the STAT pathway is typically a stress-responsive pathway, playing a modest role in normal conditions but becoming predominant under stress conditions, 5 a characteristic shared with Hsp22, as shown here. Second, overexpression of STAT3 in the heart promotes the development of concentric, adaptive hypertrophy, 5 which is comparable to that reported in the Hsp22 TG mouse. 2, 3 Third, STAT3 is central to the cardioprotection by the second window, or delayed phase, of ischemic preconditioning. 22 Again, overexpression of Hsp22 provides cardioprotection that is quantitatively equivalent to that of the second window of ischemic preconditioning. 8 Fourth, the major mediator of the second window of ischemic preconditioning is iNOS, 23 which is induced by NF-B and STAT3 in response to cardiac stress. 24 We show here that Hsp22 is sufficient to activate both transcription factors and that iNOS expression is virtually abolished on stress in the Hsp22 KO mouse. Fifth, the observed phenotype of eccentric hypertrophy is strikingly similar to that reported on pressure overload in a gp130 KO model that prevents STAT activation. 25 Similarities between Hsp22 and STAT3 exist at the mitochondrial level as well. We show that Hsp22 localizes inside the mitochondria, where it coprecipitates with STAT3. A translocation of STAT3 to the mitochondria has recently been described in which it stimulates respiration by activation of complexes I and II. 6 Interestingly, a mitochondrial localization of Hsp22 has been reported in Drosophila, where it is associated with increased respiration, resistance against oxidative stress, and prolonged lifespan. 26, 27 Our models of Hsp22 TG and KO might therefore offer a useful tool to further investigate in vivo the specific roles and mechanisms of regulation of mitochondrial STAT3.
In addition to changes in STAT3, the response of the Hsp22 KO mouse to pressure overload also includes an impaired activation of several signaling mechanisms involved in cardiac cell survival and growth, including Akt. We have shown that Hsp22 is an activator of Akt through stimulation of phosphatidylinositol-3 kinase, which is itself activated by the bone morphogenetic protein receptor. 18 Activation of Akt mediated by Hsp22 can be responsible for the subsequent stimulation of NF-B. 28 However, Hsp22 also activates p38 MAP kinase, another well-known activator of NF-B. 28 Interestingly, p38 MAP kinase also mediates the S727 phosphorylation of STAT3 responsible for its mitochondrial translocation. 6, 29 We also show here a deactivation of ERK1/2 at the acute phase of TAC in the KO, which could also be due to the absence of STAT3 activation because janus kinase, the upstream activator of STAT3, is an ERK activator. 5 Together with p38 MAP kinase, ERK can also phosphorylate S727 STAT3. 30 Although the role of STAT3 in the cardiac stress response is still emerging, its role in the mechanisms of growth and proliferation of cancer is well described. Deregulation of Hsp22 expression has been described in cancer as well. 31 Interestingly, a recent report showed that mitochondrial STAT3 is responsible for Ras-mediated cellular transformation. 32 As mentioned above, mitochondrial Hsp22 increases lifespan in Drosophila. It is therefore possible that a mitochondrial interaction between STAT3 and Hsp22 also participates in tumor growth.
Conclusions
Hsp22 represents a previously undescribed activator of both nuclear and mitochondrial functions of STAT3, and its deletion accelerates the transition into heart failure. Altogether, our observations provide a novel mechanism responsible for activation of stress-inducible signaling pathways in the cardiac response to overload. Preemptive activation of STAT3 by Hsp22 can be of therapeutic potential to activate critical survival pathways in patients with chronic cardiac overload who are at risk of subsequent myocardial damage and heart failure.
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